Biotech and Pharma Stocks Await Q1 Earnings But Gene Editing Stocks Sell-Off
Speculative Biotech Stocks Sell-Off in Profit Taking: Gene Editing Biotech stocks held current levels but small caps and speculative stocks sold off with the XBI down 1%. Most large caps were in the green with an upgrade from Goldman Sachs helping Merck (MRK) up 2.4% with a bullish story on...
Biotechs Stalled and Get No Help From Monday’s Market Moves…Updates
Updates: 4/19/18 GWPH hits $143 new high, then sold off holding $134 level, after big move from $105 on cannabis drug for severe epilepsy FDA Advisory go ahead. Biotechs broadly in the red except CRSP up 6.4% and NVCR up 5%. AstraZeneca (AZN) gained US approval for 1st line use of lung cancer...
Biotechs Bounce off Bottom on Novartis Deal but Fades Later in the Day…Updates
Updates 4/11/18 Biotechs Holding Above Recent Bottom 4/6/18 FBT up 2.8% over 5 days, up 6% YTD XBI up 1.77% over 5 days, up 2.19% YTD IBB down 0.72% over 5 days, down 3.67% YTD Busted Biotechs Review In our "Busted Biotechs" article we said that the XBI trade at 83-84 would be good, now at 89....
Busted Biotech Stocks: Where Do We Go From Here?…Updates
4/17/18 Latest portfolio changes are working: CELG at $88, XBI at $84. all based on technicals. ========== Busted Biotech Stocks Get No Help From the Overall Market 4/8 Update XBI down 3% on 4/6 and BELOW SMA 20 AT $82.90. Bellwether Mid-Caps red screen-two up stocks CLVS ICPT ; NKTR down 7.48%...
2018 Large Cap Biopharmaceutical Stocks : First Quarter Performance Update
2018 Large Cap Biopharmaceuticals - Performance Compared to ETFs It has been a rough start for large cap biopharmaceutical stocks but the ETFs (FBT) and (XBI) still outperformed the SPY YTD and over 12 months. Most Individual stocks lagged unless you owned Abbvie (ABBV) or Vertex...